Central Ohio Urology Group First in Region to Office Micro-Ultrasound for Most Accurate Prostate Cancer Diagnosis

Central Ohio Urology Group, one of the largest urology practices in Central Ohio and the Columbus MSA, has acquired ExactVu™ Micro-Ultrasound (Micro-US), specifically designed to aid in the diagnosis of prostate cancer using real-time imaging for biopsy guidance. ExactVu dramatically improves visualization of suspicious areas of the prostate with 300 percent higher resolution over standard ultrasound, and has shown to be comparable to mpMRI for detecting clinically significant prostate cancer. ExactVu’s targeted biopsies help urologists determine, with certainty, the grade and stage of cancer, when detected.

Central Ohio Urology Group (COUG) serves patients throughout Central Ohio with 21 urologists practicing at 15 locations, including a prostate cancer center and an ambulatory surgery center. COUG invests in the most advanced technologies to give patients the best possible urological care.

Adam C. Weiser, M.D., of Central Ohio Urology Group, stated, “I remember as a child the leap from black-and-white TV to color TV. Conventional ultrasound to ExactVu is the same kind of paradigm shift in visualization. We did not know what we were missing until someone showed us the difference, side by side. We hope to use the increased definition of ExactVu to cut down the number of biopsies and avoid false negatives that have plagued the previous generation of biopsy machines.”

Typically, when the urologist performs a standard ultrasound to detect prostate cancer and guide the biopsy, it is often done blind, with the possibility of results showing a false negative or under-graded cancer diagnosis.

With an imprecise diagnosis and to avoid any risk, the urologist may recommend a radical prostatectomy or radiotherapy to surgically remove or radiate the entire prostate, which may cause long-term side effects of urinary incontinence and erectile dysfunction.

Using ExactVu Micro-US, urologists can better detect smaller abnormalities and evaluate the grade and stage of the cancer. Its design also minimizes the risk of infection during biopsy through a transperineal approach.

In addition to providing comparable sensitivity to an MRI scan, ExactVu Micro-US is done in the urologist’s office. The patient does not have to travel for the MRI and return to the urologist’s office for the biopsy. Also, for some patients who are claustrophobic or have a pacemaker, an MRI may be prohibitive.

For more information about ExactVu Micro-US at Central Ohio Urology Group visit www.centralohiourology.com.

Dr. Jonathan J. Corbett Joins Central Ohio Urology Group

Central Ohio Urology Group (COUG) is pleased to announce that Jonathan J. Corbett, M.D., has joined the practice. Through a network of 15 offices in the region, Central Ohio Urology Group is one of the nation’s leading providers of comprehensive urological services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. COUG’s facilities include a urology-specific surgery center, as well as an Advanced Prostate Cancer Clinic. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, which supports urology practices and is backed by NMS Capital.

Mark Cherney, CEO of Central Ohio Urology Group and U.S. Urology Partners, stated, “I am excited to welcome Dr. Corbett to our practice. He provides a great blend of top-notch clinical education and knowledge with a strong passion for providing community-based care. He takes particular interest in co-managing urological conditions with his primary care partners: kidney stones, prostate cancer, general urology, robotics and endourology, to name a few. I also expect that he will be an active member of the community, and that will be evident over the course of the months and years to come.”

Dr. Corbett was born and raised in Cincinnati. He attended The Ohio State University, where he earned his Bachelor of Science in Biology. Dr. Corbett went on to attend Wright State University Boonshoft School of Medicine for his medical degree, where he graduated as a member of both the Alpha Omega Alpha and the Gold Humanism Honor Societies. He completed a residency in Urology at the University of Cincinnati.

“My goal is to manage patients’ urologic issues with as little disruption to their normal lives as possible,” said Dr. Corbett. “Shared decision making is a cornerstone of my practice and important to help patients make the best decisions based on their individual condition and goals. I firmly believe that collaboration between providers on our patients’ healthcare is key to providing the best possible care.”

“My wife and I met during medical school, and we are excited to return to her hometown of Columbus. I share Central Ohio Urology Group’s commitment to serve the community and am honored to join such an outstanding team of caring professionals,” added Dr. Corbett.

Dr. Corbett is now accepting patients and will primarily be working from the group’s offices at 350 W. Wilson Bridge Road, Worthington, OH 43085 and the Central Ohio Urology Surgery Center at 701 Tech Center Drive, Gahanna, OH 43230. Please contact (614) 396-2684 to make an appointment or for additional information.

About Central Ohio Urology Group

Central Ohio Urology Group (COUG) is one of the nation’s leading providers of urological services with a network of 15 offices in the region. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides comprehensive services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, which has plans to support urology practices nationally and is backed by NMS Capital. For more information, visit www.centralohiourology.com and www.us-uro.com.

Acclaimed Author and Entrepreneur Alison Cherney Releases New Book, Decode Karma

We’ve all heard karma blamed for everything from lost love to difficult business relationships, but few people can truly define what it is and how it influences our behavior and life. Decode Karma, a new book from nationally recognized speaker, writer and business expert Alison Cherney, provides an unprecedented level of research to understand and leverage the mysterious force, including exploration of 160 karmic games.

Through her consulting firms Decode My Life and Cherney & Associates, Inc., Cherney has spent decades advising hundreds of start-ups to Fortune 100 companies on strategies and tactics to grow their businesses. Along the way, she has become a sought-after speaker and prolific writer publishing seven books and more than 100 articles.

“The key to any company’s growth is its people. Karma is the ‘door’ to answer the questions that are in the way of people’s success,” stated Cherney. “During my years of leading in-depth training programs on communication, conflict resolution and business growth, I recognized that there were deep underlying issues that couldn’t be resolved through traditional training or counseling methods.”

In Decode Karma, Cherney introduces The Karma Checklist, developed through her extensive research to help readers identify which of the 160 karma game(s) they are engaged in with another individual or group of people. Understanding this dynamic can help resolve the process with that person and/or situation.

“Karma is the law of attraction and balance, and it plays a critical role in everything from interpersonal relationships to business to wealth,” said Cherney. “When we commit a karmic action, we must pay the debt we created and learn the karmic lesson. Amazingly, there is little recorded information on the specific actions that create karma. My research describes karmic actions, how to identify them in your life, and how to get them resolved—leading to more fulfillment and greater success.”

Decode Karma is available for easy online download or print and can be purchased from Amazon or Barnes & Noble.

About Decode My Life

The mission of Decode My Life is to plant the seeds of success for business growth. Decoding means to figure out the who, what, when, where and how of the events that are really playing out in your employee’s daily life. Most of us just focus on what is happening on the physical level of our lives, when in fact, there are mental, emotional and spiritual forces that are typically at play. Our consultants and speakers are available on an individual or group basis and have extensive knowledge and understanding of business issues. For more information, visit www.decodemylife.com.

 

Central Ohio Urology Group and U.S. Urology Partners Adds Physician Recruitment Expert Audrey Barker

Central Ohio Urology Group (COUG) and U.S. Urology Partners have expanded their executive teams with the addition of Audrey Barker, MBA, Vice President of Physician Recruitment.

Through a network of 15 locations in the region, COUG is a leading provider of comprehensive urological services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital, with plans to support urology practices nationally.

“We are very excited to welcome Audrey to the COUG and U.S. Urology Partners teams,” said Mark Cherney, CEO. “She’s a thought leader and author in the recruitment industry with a highly successful track record. We look forward to leveraging her expertise to grow our urology practices both within Central Ohio and in additional practices supported by U.S. Urology Partners.”

Barker has an extensive background in physician recruitment and business development, most recently leading the recruitment efforts of 9 hospitals, 7 freestanding emergency departments and over 120 outpatient facilities for Kettering Health Network in Dayton, Ohio, while providing direct contractual and relational support to more than 500 employed physicians. During her time at Kettering, she successfully placed more than 225 physicians in the region and served practices of multiple sizes and affiliations, including hospital employed positions, multi-specialty private groups and independent practitioners, as well as research and academically focused clinicians. Barker published The Physician Recruiting Standard – The Delta Companies in 2018, which discusses strategies for physician retention and preventing burnout.   

“Recruiting for Central Ohio Urology Group and U.S. Urology Partners offers the ability to have laser focus on urological and oncological specialties with a goal to provide expert service to physicians. I am excited to partner with the leadership in developing key processes for growth and strategic alliances across medical and commercial enterprises,”  said Barker. “Central Ohio Urology Group is an impressive regional organization with a vision for growth and service to the greater Columbus area. I am thrilled to be on board and eager to get started,” said Barker.

“I take great pride in serving physicians – facilitating for them and their families in helping to shape their future. My approach is personal and relational in communication style, as I find this critical in establishing strong partnerships. I feel honored to play an integral role in finding the perfect fit for a physician’s unique skills and interests both personally and professionally,” stated Barker.

About Central Ohio Urology Group

Central Ohio Urology Group (COUG) is a leading provider of urological services with a network of 15 locations in the region. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. For more information, visit www.centralohiourology.com.

About U.S. Urology Partners

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefiting from operational support, management expertise and deep financial resources of a partner. The strength and experience of U.S. Urology Partners enables practices to concentrate on what they do best – delivering the highest level of care to patients. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally. For more information, visit www.us-uro.com.

US Foot & Ankle Specialists Expands Presence in Pennsylvania with the Acquisition of Harrisburg Foot & Ankle Center

US Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Harrisburg Foot & Ankle Center (“HFA” or the “Company”). Headquartered in Harrisburg, Pennsylvania, Harrisburg Foot & Ankle Center has been providing podiatric care through its three locations in Harrisburg, Mechanicsburg and Newport, Pennsylvania since 1995. Dr. Allan Grossman will continue leading the practice with the additional support of USFAS.

“We are very excited to partner with Dr. Allan Grossman and his practice. He and his team have built a great clinical reputation for themselves over the past twenty-four years, and we look forward to having them be a part of the USFAS family as we expand our footprint in Pennsylvania. Our partnership with NMS allows us to continue executing on our stated strategy of partnering with like-minded practices in our existing and adjacent geographies. Our strength and success come from dedicated physician leadership and clinical support staff, who are focused on providing patients with quality care and achieving successful outcomes,” said Brett Richey, Chief Executive Officer of USFAS.

Dr. Allan Grossman added, “I am proud to partner with a leading podiatry platform such as USFAS. The partnership will offer our patients greater support as we experience our next phase of growth. In addition to continuing to receive personal podiatry care from our local podiatrists who place a high value on patient satisfaction and quality care, our patients will benefit from the array of functional support USFAS has to offer them.”

Harrisburg Foot & Ankle Center will maintain its three locations in Harrisburg, Mechanicsburg and Newport, Pennsylvania and continue providing complete podiatry care while benefitting from USFAS’s extensive administrative and support services, including investments in clinical compliance, information technology, electronic medical records, revenue cycle management, payor credentialing and contracting, finance and accounting, human resources and business development.

About US Foot & Ankle Specialists

USFAS is a leading provider of podiatric services providing a full range of specialty services for the advanced treatment of foot and lower extremity conditions through Board Certified and Board Qualified podiatrists. Headquartered in Charlottesville, Virginia, USFAS provides services through a growing network of nearly 40 offices in states including Maryland, Virginia, Pennsylvania, North Carolina and Washington, D.C and over 60 Board Certified podiatrists.

For additional information on USFAS, visit the company’s website at www.footandankle-usa.com.

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies.  The Firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services.

For additional information on NMS, visit the firm’s website at www.nms-capital.com.

U.S. Urology Partners Supports Growth of Independent Practices; Urology Practices Under Pressure from Increasing Economic Demands, Hospital Consolidation

Like other medical professionals, urology practices face a number of operating challenges that strain their resources and reduce profitability. These include shrinking reimbursement rates, burdensome overhead and administrative costs, and an ever-changing regulatory environment.

Seeking to escape these pressures, some practices have joined a hospital or health system. However, once acquired by a hospital, physicians become hospital employees with little independence or ability to profit from their performance and productivity. Their contracts can also be terminated at any time.

For practices seeking an alternative to hospital acquisition, partnering with a group like U.S. Urology Partners can help support the business aspects of the practice while freeing urologists to focus on patient care.

“We see partnering with U.S. Urology Partners as a great opportunity for urologists who wish to retain clinical independence but also want greater management support and financial strength,” said Mark Cherney, CEO, U.S. Urology Partners. “The healthcare environment continues to become more complex and demanding for physicians. Our goal is to allow physicians to focus on clinical care while our skilled experts optimize other business aspects of the practice.”

U.S. Urology Partners has compiled Cherney’s answers to some of the most common questions from practices considering partnership opportunities. U.S. Urology is focused on supporting urology practices through operational expertise, management skills and deep financial resources. The firm’s physician partners retain their independence, avoid hospital employment, and drive clinical leadership and patient care. The Q&A can be found at www.us-uro.com/questions-answers/

Among the questions are:

  • How do practices benefit operationally?
  • What are the financial benefits?
  • How will it help physicians close to retirement?
  • What will be the outcome for middle-aged and younger physicians?

For more information, contact Mark Cherney, Chief Executive Officer, at (614) 944-4834 or mcherney@us-uro.com.

About U.S. Urology Partners

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefiting from operational support, management expertise and deep financial resources of a partner. The strength and experience of U.S. Urology Partners enables practices to concentrate on what they do best – delivering the highest level of care to patients. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally. www.us-uro.com  

U.S. Urology Partners Expands Senior Management Team; New CFO, CDO Have Extensive Healthcare Backgrounds

U.S. Urology Partners has added two highly experienced healthcare experts to its executive team. Anthony Bond, CPA, has joined the company as Chief Financial Officer, and Chad Baldwin will serve as Chief Development Officer.

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources. Physician partners retain their independence, avoid hospital employment, and drive clinical leadership and patient care.

“We are very pleased to add Anthony and Chad to the U.S. Urology Partners team,” said Mark Cherney, CEO, U.S. Urology Partners. “It’s a testament to the strength of our company as well as our vision for the future that they chose to align with us. They understand and embrace our goal: to enable urologists to focus on clinical care while our skilled experts help optimize other business aspects of the practices.”

Anthony Bond, CPA, is a seasoned financial executive with more than 20 years of experience in the healthcare service sector. Most recently as CFO of IMAC Holdings, a provider of regenerative services as an alternative to surgery, he led the company from cash-based operations through an IPO, taking the company public on the NASDAQ. He previously ran Bond Consulting Group, providing a variety of strategic financial services to organizations while arranging for financing, starting, managing and ultimately selling three businesses. Mr. Bond’s experience includes serving as Group CFO and Vice President for Symbion, an owner of more than 60 ambulatory surgery centers and hospitals; Vice President of Financial Operations for Inspiris, Inc.; and Vice President of National Accounts for Passport Health Communications.

Chad Baldwin is a senior executive with nearly two decades of healthcare services experience in finance, operations and business development. His background includes serving as Vice President of Hospital Operations for Surgery Partners, Inc., an integrated outpatient healthcare company with 180 facilities in 32 states. Mr. Baldwin’s focus was on development and acquisition efforts aimed at surgical hospitals, ambulatory surgery centers, physician practices and urgent care. During his decade with Surgery Partners, Mr. Baldwin served as Vice President of Acquisitions and Development as well as interim Chief Executive Officer of Lubbock Heart and Surgical Hospital. Previously, Mr. Baldwin was a Senior Accountant with Psychiatric Solutions, Inc. as well as Ernst and Young, LLP.

About U.S. Urology Partners

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources of a partner. The strength and experience of U.S. Urology Partners enables practices to concentrate on what they do best – delivering the highest level of care to patients. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally. Learn more at www.us-uro.com.

US Foot & Ankle Specialists Expands Presence in Virginia with First Acquisition Following Partnership with NMS Capital

US Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Affiliated Podiatrists, P.C. (“AP”). Based in Newport News, Virginia, AP has been providing podiatric care through its three locations to the Newport News area for over 75 years. AP is led by Dr. Howard Roesen, who will continue to lead the practice and benefit from the additional administrative support provided by USFAS.

“Dr. Roesen is a podiatrist we have known for several years now and are thrilled to bring into the USFAS family. He is a well-respected podiatrist with a great clinical reputation. This acquisition allows us to quickly build scale in a desirable market and expand our presence in Virginia. Furthermore, our partnership with NMS affords us the support and resources to execute on our strategy of partnering with high-quality practices and providers in existing and new markets as we seek to build USFAS as the provider of choice in the podiatric industry,” said Brett Richey, Chief Executive Officer of USFAS.

Dr. Howard Roesen commented, “I am delighted to partner with USFAS, a leading podiatry platform in the Mid-Atlantic region with a great culture of supporting its podiatrists. My practice and our patients will greatly benefit from being a part of a larger organization with more services and support for our patients to provide even better patient care.”

David Peterson, Managing Director at NMS, added, “We are very excited to partner with Dr. Roesen and his practice, our first affiliation post NMS’s initial investment with USFAS. AP is a high-quality podiatry practice that exemplifies what we look for in other podiatry practices interested in joining USFAS. This is our first of many affiliations, and we look forward to the future growth of the overall platform.”

As part of the affiliation, AP will benefit from USFAS’s extensive administrative and support services, including investments in clinical compliance, information technology, electronic medical records, revenue cycle management, payor credentialing and contracting, finance and accounting, human resources and business development.

About US Foot & Ankle Specialists

USFAS is a leading provider of podiatric services providing a full range of specialty services for the advanced treatment of foot and lower extremity conditions. Headquartered in Rockville, Maryland, USFAS provides services through a growing network of nearly 40 offices in states including Maryland, Virginia, Pennsylvania, North Carolina and Washington, D.C and over 60 Board Certified and Board Qualified podiatrists. USFAS is an affiliate of Foot & Ankle Specialists of the Mid-Atlantic and NMS Capital, with plans to expand nationally.

For additional information on USFAS, visit the company’s website at www.footandankle-usa.com.

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The Firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services.

For additional information on NMS, visit the firm’s website at www.nms-capital.com.

Importance of Oral Cancer Screenings Recognized in April by Marquee Dental Partners; Supports Oral Health with Special Offerings

The warmer weather and longer days of April may bring smiles, but dental professionals have a much more serious reason to recognize the month. April is designated Oral Cancer Awareness month in an effort to bring awareness to the approximately 53,000 Americans in 2019 who will be diagnosed with oral and oropharyngeal cancer (cancers of the mouth and throat). According to the American Cancer Society, approximately 10,860 people will die of these cancers.

“The statistics are shocking, and early detection is critical,” says Fred Ward, CEO of Marquee Dental Partners, a premier dental health organization dedicated to making dentists and their patients the priority. “Regular dental check-ups are important, as trained oral health professionals can find oral and oropharyngeal cancers – and pre-cancers – early, which supports more successful outcomes.”

In honor of Oral Cancer Awareness, Marquee Dental has several special offerings for both existing and new patients. These include:

  • Oral cancer screening – free oral cancer screening for all current and new patients ($40 value);
  • New patients – $59 new patient special includes exam and X-rays, and patients receive a free electric toothbrush upon completion of a cleaning;
  • Complete unfinished treatment – any current patients who complete a previously diagnosed treatment can receive a free electric toothbrush.

April is also National Facial Protection Month, which reminds children and adults to protect their face and head when participating in sports. The use of helmets and mouth guards can easily prevent many oral and facial injuries.

Marquee Dental’s 28 practices in Tennessee, Kentucky and Alabama are committed to providing the best oral healthcare services possible. Marquee dentists and their staffs help educate patients to be proactive in their dental care and prevent dental disease while providing world-class, convenient and affordable services in a caring, comfortable and safe environment.

About Marquee Dental Partners

Marquee Dental is a premier dental support organization dedicated to making dentists and their patients the priority. By providing dentists with both the support and the clinical autonomy they need to succeed, Marquee enables them to focus their attention on providing the best oral health services possible. Led by a team of highly accomplished industry veterans, the privately held company is based in Nashville, Tennessee. For more information, visit www.marqueedentalpartners.com.

U.S. Urology Partners Adds Experts to Management Team, Board; Group Focused on Helping Urology Practices Nationwide Retain Independence

With hospitals aggressively acquiring specialty practices, physicians may feel they have little choice in today’s healthcare environment. U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources of a partner.

“Our goal at U.S. Urology Partners is to enable practices to concentrate on what they do best – delivering the highest level of care to patients,” said Chief Executive Officer Mark Cherney. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally.

“We are very pleased that nationally recognized urologist and Past President of the Large Urology Group Practice Association (LUGPA), Peter Knapp, M.D., of Strand Diagnostics, has joined our Board of Directors,” Cherney stated.

“I believe that U.S. Urology Partners can help practices that are trying to balance maintaining their independence from hospitals with the need for growth capital and operational support,” said Knapp. “Shrinking reimbursement and growing regulations are forcing urology practices to re-examine their traditional ways of conducting business, and U.S. Urology Partners can play a critical role in the success of many practices.”

In addition to Cherney and Knapp, the Board of Directors of U.S. Urology Partners includes urologists William Bloch, M.D. and Rush Patel, M.D. of Central Ohio Urology Group, as well as partners and executives from NMS Capital, including Martin E. Chavez, Luis A. Gonzales and Donza Worden.

U.S. Urology Partners also announced several new additions to the executive team who bring extraordinary levels of leadership, experience and expertise in the field of urology and practice management. Joining the executive management team of Mark Cherney, Chief Executive Officer, and Dante Ventresca, Chief Information Officer, are Peter Myhre, Director, Physician Partnerships; Jay Rom, Vice President, Ambulatory Surgery Center Operations; and Greg Long, CPA, Chief Financial Officer.

To discuss partnership opportunities, contact Mark Cherney, Chief Executive Officer, at (614) 944-4834 or markcherney@usuropartners.com

About U.S. Urology Partners

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources of a partner. The strength and experience of U.S. Urology Partners enables practices to concentrate on what they do best – delivering the highest level of care to patients. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally. www.usuropartners.com

About Central Ohio Urology Group

Central Ohio Urology Group (COUG) is a leading provider of urological services with a network of 16 locations in the region. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of urological services, including men’s health, women’s health, cancer care, advanced treatment options for bladder and prostate cancer, and radiation oncology. www.centralohiourology.com

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services. www.nms-capital.com